Massachusetts Financial Services Co. MA Cuts Holdings in GE HealthCare Technologies Inc. $GEHC

Massachusetts Financial Services Co. MA reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,356,078 shares of the company’s stock after selling 17,063 shares during the period. Massachusetts Financial Services Co. MA owned 0.30% of GE HealthCare Technologies worth $101,841,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in GE HealthCare Technologies by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock valued at $3,859,622,000 after buying an additional 703,903 shares in the last quarter. Dodge & Cox boosted its position in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. State Street Corp boosted its position in shares of GE HealthCare Technologies by 1.9% during the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after acquiring an additional 372,755 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 2.0% in the second quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock valued at $881,060,000 after purchasing an additional 231,302 shares in the last quarter. Finally, Norges Bank bought a new stake in GE HealthCare Technologies in the second quarter worth $468,120,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $78.83 on Wednesday. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a 50-day moving average price of $81.57 and a 200-day moving average price of $77.11. The firm has a market capitalization of $35.91 billion, a PE ratio of 16.29, a price-to-earnings-growth ratio of 3.18 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same period in the prior year, the firm posted $1.14 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on GEHC shares. BTIG Research reaffirmed a “buy” rating and set a $87.00 price target on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Citigroup upped their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Jefferies Financial Group increased their price target on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Wells Fargo & Company dropped their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Finally, Barclays assumed coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective on the stock. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $89.83.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.